DrugPatentWatch Database Preview
Actavis Labs Fl Inc Company Profile
What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?
ACTAVIS LABS FL INC has sixty-three approved drugs.
There are four tentative approvals on ACTAVIS LABS FL INC drugs.
Summary for Actavis Labs Fl Inc
| US Patents: | 0 |
| Tradenames: | 51 |
| Ingredients: | 49 |
| NDAs: | 63 |
Drugs and US Patents for Actavis Labs Fl Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | QUINAPRIL HYDROCHLORIDE | quinapril hydrochloride | TABLET;ORAL | 076049-001 | Jan 14, 2005 | DISCN | No | No | Start Trial | Start Trial | |||||
| Actavis Labs Fl Inc | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 077408-002 | Mar 2, 2009 | DISCN | No | No | Start Trial | Start Trial | |||||
| Actavis Labs Fl Inc | TAMOXIFEN CITRATE | tamoxifen citrate | TABLET;ORAL | 070929-001 | Feb 20, 2003 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
